Published : Apr-2017
No. of Pages : 121
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Bacterial Vaginosis Therapeutics Clinical Trials 30
Prominent Drugs 32
Latest Clinical Trials News on Bacterial Vaginosis 33
Mar 30, 2017: VivaGel BV phase 3 trials for prevention of BV completed 33
Clinical Trial Profile Snapshots 34
Appendix 116
Abbreviations 116
Definitions 116
Research Methodology 117
Secondary Research 117
About GlobalData 118
Contact Us 118
Source 119
List of Tables
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region, 2017* 6
Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 12
Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 14
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 18
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32
List of Figures
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Bacterial Vaginosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
Bacterial Vaginosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
Bacterial Vaginosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Bacterial Vaginosis Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
Bacterial Vaginosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 12
Bacterial Vaginosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 13
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, G7 Countries (%), 2017* 14
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Bacterial Vaginosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Bacterial Vaginosis to Infectious Disease Clinical Trials, E7 Countries (%), 2017* 17
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Bacterial Vaginosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Bacterial Vaginosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Bacterial Vaginosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Bacterial Vaginosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Bacterial Vaginosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
Bacterial Vaginosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32
GlobalData Methodology 117
